Top events
Valorant
Marvel Rivals
Deadlock
2025-06-14 14:56:33
2025-06-15 14:56:33
2025-06-16 14:56:33
2025-06-17 14:56:33
Scores
Valorant Marvel Rivals Deadlock Counter-Strike 2 Soon
VCT 2025: EMEA Stage 1
Group Stage (Round-Robin)
Gentle Mates France
2025-04-17 14:46:04
0 - 2
Best of 3
Finished
BBL Esports Turkey
All Games
Map 1 Lotus
Map 2 Haven
Overview
Advanced
Kills
Gentle Mates
Player
kda
+/-
KAST
ACS
ADR
Rating 3.0
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
Show advanced stats
35 / 31 / 12
+4
78.05%
242.29
155.59
1.20
37%
150
4
3
+1
9
2
-
28 / 29 / 9
-1
73.17%
194.71
132.49
1.05
38%
59
1
2
-1
4
2
-
27 / 31 / 4
-4
65.85%
193.32
119.56
0.93
45%
112
5
3
+2
5
1
-
24 / 29 / 12
-5
63.41%
177.49
110.05
0.89
36%
122
4
7
-3
7
3
-
10 / 36 / 6
-26
56.10%
86.73
63.68
0.49
24%
57
3
9
-6
2
8
-
Player
kda
+/-
ADR
Rating 3.0
ACS
KAST
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
35 / 31 / 12
+4
155.59
1.20
242.29
78.05%
37%
150
4
3
+1
9
2
-
28 / 29 / 9
-1
132.49
1.05
194.71
73.17%
38%
59
1
2
-1
4
2
-
27 / 31 / 4
-4
119.56
0.93
193.32
65.85%
45%
112
5
3
+2
5
1
-
24 / 29 / 12
-5
110.05
0.89
177.49
63.41%
36%
122
4
7
-3
7
3
-
10 / 36 / 6
-26
63.68
0.49
86.73
56.10%
24%
57
3
9
-6
2
8
-
Player
kda
+/-
KAST
ACS
ADR
Rating 3.0
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
Show advanced stats
42 / 21 / 13
+21
82.93%
261.54
172.29
2.00
29%
166
3
1
+2
14
2
1
31 / 19 / 20
+12
82.93%
202.24
123.46
1.39
19%
133
1
1
0
8
1
2
35 / 29 / 8
+6
68.29%
255.73
159.24
1.14
29%
234
11
10
+1
8
3
1
25 / 28 / 20
-3
82.93%
181.51
117.66
0.93
15%
100
5
3
+2
4
3
-
23 / 27 / 13
-4
70.73%
166.85
108.56
0.88
19%
98
4
2
+2
5
2
1
Player
kda
+/-
ADR
Rating 3.0
ACS
KAST
hs%
Impact
fk
fd
F+/-
mk
Trade
Clutch
42 / 21 / 13
+21
172.29
2.00
261.54
82.93%
29%
166
3
1
+2
14
2
1
31 / 19 / 20
+12
123.46
1.39
202.24
82.93%
19%
133
1
1
0
8
1
2
35 / 29 / 8
+6
159.24
1.14
255.73
68.29%
29%
234
11
10
+1
8
3
1
25 / 28 / 20
-3
117.66
0.93
181.51
82.93%
15%
100
5
3
+2
4
3
-
23 / 27 / 13
-4
108.56
0.88
166.85
70.73%
19%
98
4
2
+2
5
2
1

Past Matches

Date
Match
Event

Past Matches

Date
Match
Event

Head To Head